📰 Rhonda Hellums News
Rhonda Hellums News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rhonda Hellums. Real-time updates on events, politics, business and more.
March 13, 2024
Silence also announced positive topline 36-week data from ongoing phase 2 study of zerlasiran in patients with high lipoprotein Company to host conference call and webcast today at 8 a.m. EDT / 12...
May 16, 2023
Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision
March 21, 2023
Operator: Good day and thank you for standing by. Welcome to the Silence Therapeutics 2022 Annual Results Conference Call and Webcast. Please be advised that todays conference is being recorded.
March 15, 2023
Company to host fourth quarter conference call and webcast today at 8 a.m. EDT 12 p.m. GMT Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology
March 15, 2023
15.03.2023 - Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today reported its ...
March 17, 2022
Positive SLN360 data to be presented in late breaker at the American College of Cardiology (ACC) Annual Meeting on April 3, 2022 SLN124 phase 1 study in thalassemia now fully enrolled; on-track for
February 24, 2022
Silence Therapeutics, Totus Medicines and Poseida Therapeutics all adjust as they welcome new members to their leadership teams.
February 21, 2022
Mark Rothera steps down as President and CEO Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a leader in the discovery, development and delivery of novel short interfering ribonucleic